Get In Touch

Medication-assisted Treatment Market: Overview

Medication-assisted treatment has become a part of treatment modalities that are combined with counseling and behavioral therapies to provide all-inclusive approach to treating substance use disorders. The medication-assisted treatment market has witnessed its use in alcohol and opioid use disorders. Growing traction of evidence-based treatment options among healthcare providers has been driving the evolution of the market.

In recent years, a number of medications are used for treating opioid use disorder, a worldwide problem. Some of the medications used to treat opioid use disorders (OUD) have been associated by stigma, since they are heavily regulated by agencies, such as the FDA.

The WHO has been promoting the adoption of medication-assisted treatment to end the opioid crisis. The market has been witnessing the demand for such medications for inpatient and outpatient facilities. Key product types in the medication-assisted treatment market are buprenorphine, methadone, and naltrexone. Key end users include rehabilitation clinic, hospital, and home care setting

Are you a start-up willing to make it big in business? Grab an exclusive Sample for this report

Medication-assisted Treatment Market: Key Trends

The medication-assisted treatment (MAT) market has been witnessing rise in acceptance of such medications in drug abuse habits. MAT has become integral part of practicing counselling and therapies, and in many cases being preferred over treatment methods. Opioid overdose prevention medications are growing in popularity. Prevention of opioid overdose is becoming a mounting concern for healthcare providers. Methadone in its liquid form is growing in demand in the medication-assisted treatment market. Patient providers are increasingly benefitting from the range of treatments that can be used for opioid use disorders (OUD). The variety of MAT medications expand the options for patient populations, and hence is imperative.

Growing trend of combining MAT in counseling and psychosocial support is fueling the prospects in the medication-assisted treatment (MAT) market. Over the years, the support has moved from hospital setting to home care settings. Growing number of people in the U.S. who struggle with opioid use disorders and drug abuse disorders has spurred the opportunity generation for drug makers in the market.

Do you want to assess potential implications of COVID-19 pandemic on your business and boost your preparedness? Grab an exclusive PDF Brochure for this report!

Medication-assisted Treatment Market: Competitive Analysis and Key Developments

The MAT market has seen regulatory agencies continually making efforts need for continuing MAT should be re?evaluated periodically. For instance, FDA regularly updates in finalizing new policies to development of new buprenorphine treatments for opioid use disorders. Drug makers in the MAT market has also benefitted from public meeting on patient-focused drug development for opioid use disorder. The growing approval of non-opioid treatments for opioid withdrawal symptoms especially in adults has boosted the growth of the medication-assisted treatment market. Due to high out-of-pocket expenditure for MAT, payers are accepting open models.

Some of the key industry stakeholders in the medication-assisted treatment market are Rosemont Pharmaceuticals Limited, Titan Pharmaceuticals, Inc, Teva Pharmaceuticals, and BioDelivery Sciences International, Inc.

Medication-assisted Treatment Market: Regional Analysis

Some of the key regional markets are Europe, North America, East Asia, South Asia, Latin America, and Middle East and Africa. Of these, North America has occupied a high share in the MAT market. Government and healthcare professionals are accepting MAT as a part of treatment modality. Europe is also a promisingly lucrative regional market. These regions are expected to see new revenue streams on the back of the increased focus of governments and healthcare providers to address the drug abuse and opioid use disorders. Regional agencies are also focusing on ensuring MAT medications and child safety. Healthcare providers in the U.S. are promoting the use of behavioral therapies. A case in point is the designing training and resources by Substance Abuse and Mental Health Services Administration

This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.

Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:

  • Customer Experience Maps
  • Insights and Tools based on data-driven research
  • Actionable Results to meet all the business priorities
  • Strategic Frameworks to boost the growth journey

The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.

The following regional segments are covered comprehensively:

  • North America
  • Asia Pacific
  • Europe
  • Latin America
  • The Middle East and Africa

The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.

Below is a snapshot of these quadrants.

1. Customer Experience Map

The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.

2. Insights and Tools

The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.

3. Actionable Results

The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.

4. Strategic Frameworks

The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.

The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:

1. What can be the best investment choices for venturing into new product and service lines?

2. What value propositions should businesses aim at while making new research and development funding?

3. Which regulations will be most helpful for stakeholders to boost their supply chain network?

4. Which regions might see the demand maturing in certain segments in near future?

5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?

6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?

7. Which government regulations might challenge the status of key regional markets?

8. How will the emerging political and economic scenario affect opportunities in key growth areas?

9. What are some of the value-grab opportunities in various segments?

10. What will be the barrier to entry for new players in the market?

Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.

Custom Market Research Services

TMR offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough.


Medicationassisted Treatment Market